Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy
- 29 February 2008
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 108 (2), 421-427
- https://doi.org/10.1016/j.ygyno.2007.10.018
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Review article: immune suppression and colorectal cancerAlimentary Pharmacology & Therapeutics, 2006
- Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunityImmunology, 2006
- Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signalingJCI Insight, 2006
- Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinomaCancer, 2006
- Vascular Endothelial Growth Factor Trap Combined with Paclitaxel Strikingly Inhibits Tumor and Ascites, Prolonging Survival in a Human Ovarian Cancer ModelClinical Cancer Research, 2005
- Dendritic Cells and Vascular Endothelial Growth Factor in Colorectal Cancer: Correlations with Clinicobiological FindingsOncology, 2005
- The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancerGynecologic Oncology, 2004
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6 (il-6), interleukin-lβ (IL-Iβ), interleukin-11 (IL-11) and tumour necrosis factor-α (TNF-α) in p53-characterised human ovarian carcinomasEuropean Journal of Cancer, 1997
- Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-α and cis-diamminedichloroplatinumCancer, 1996